Inventiva’s lead product candidate, lanifibranor, is currently in a pivotal Phase III clinical trial, NATiV3, for the treatment of adult patients with MASH, a common and progressive chronic liver ...
When Suzanne Boyles started working for the city of Buckeye's economic development team in 2013, they only had three employees. Reflecting the city's explosive growth since then, Buckeye has now ...